Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Study of New Implantable Loop Recorder

28. januar 2019 opdateret af: Abbott Medical Devices

Confirm Implantable Cardiac Monitor Study

The goal of this IDE clinical study is to evaluate the quality of the cardiac signal recordings obtained by the St. Jude Medical (SJM) Confirm Implantable Cardiac Monitor (device).

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

75

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Alaska
      • Anchorage, Alaska, Forenede Stater, 99508
        • Alaska Heart Institute
    • Arizona
      • Scottsdale, Arizona, Forenede Stater, 85251
        • Arizona Arrhythmia Research
    • Arkansas
      • Little Rock, Arkansas, Forenede Stater, 72211
        • Arkansas Heart Hospital
    • California
      • Fullerton, California, Forenede Stater, 92835-2605
        • St. Jude Hospital
      • La Jolla, California, Forenede Stater, 92037
        • Scripps Clinic
    • Oklahoma
      • Tulsa, Oklahoma, Forenede Stater, 74104
        • Oklahoma Heart Institute at Utica
    • Oregon
      • Portland, Oregon, Forenede Stater, 97225
        • Providence- St Vincent Medical Center
    • Texas
      • Austin, Texas, Forenede Stater, 78705
        • Texas Cardiac Arrhythmia Research Foundation
    • Virginia
      • Charlottesville, Virginia, Forenede Stater, 22980
        • University of Virginia

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Patients who have clinical syndromes or situations at increased risk of cardiac arrhythmias
  • Patients who experience transient symptoms that may suggest a cardiac arrhythmia
  • Patients who have been previously diagnosed with atrial fibrillation
  • Patients who are suspected to have Atrial Fibrillation (AF) but AF has not been documented
  • Patients who have provided written informed consent to participate in the study.

Exclusion Criteria:

  • Patients who are under the age of 18 years
  • Patients who have a life expectancy less than 1 year
  • Patients who are unable to comply with the follow-up schedule
  • Patients who are currently implanted with a pacemaker or defibrillator
  • Patients who the physician deems inappropriate for the study

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Diagnostisk
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Open Label
SJM Confirm Device
All patients in this study will receive the SJM Confirm device.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Sensitivity for R Waves During In-Clinic Recordings at Rest
Tidsramme: 6 weeks
The sensitivity was calculated for each recording and for each subject.
6 weeks
Sensitivity for R Waves During In-Clinic Recordings During Treadmill Exercise
Tidsramme: 6 weeks
The sensitivity for R waves during the in-clinic recordings was was calculated for each recording and for each subject.
6 weeks
Sensitivity for R Waves During In-Clinic Recordings During Hand to Hand/Shoulder Maneuvers
Tidsramme: 6 weeks
The sensitivity for R waves during the in-clinic recordings was was calculated for each recording and for each subject.
6 weeks
Positive Predictive Value (PPV) for In-Clinic Recordings at Rest
Tidsramme: 6 weeks
The positive predictive value (PPV) for the in-clinic recording was calculated for each recording and for each subject.
6 weeks
Positive Predictive Value (PPV) for In-Clinic Recordings During Treadmill Stress Test
Tidsramme: 6 weeks
The positive predictive value (PPV) for the in-clinic recording was calculated for each recording and for each subject.
6 weeks
Positive Predictive Value (PPV) During Hand to Hand/Shoulder Maneuvers
Tidsramme: 6 weeks
The positive predictive value (PPV) for the in-clinic recording was was calculated for each recording and for each subject.
6 weeks

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Interpretability of Weekly Subject Activator Recordings
Tidsramme: 6 weeks
The proportion of recording time during which the device recording was interpretable was calculated for each weekly Patient Activator recording and for each subject. A random effects model was fitted to the data.
6 weeks
Interpretability of Automatically Triggered/Symptom Driven Recordings
Tidsramme: 6 weeks
The proportion of recording time during which the device recording was interpretable for each automatically triggered/symptom driven recording and for each subject.
6 weeks
Inappropriateness of Automatically Triggered Recordings - Phase I
Tidsramme: 6 weeks
The proportion of automatically triggered recordings that were inappropriate (i.e. noise triggered)was calculated and reported using a generalized estimating equation (GEE) model for binomial outcomes to account for multiple recordings per patient.
6 weeks
Inappropriateness of Automatically Triggered Recordings - Phase II
Tidsramme: 6 weeks
The proportion of automatically triggered recordings that were inappropriate (i.e. noise triggered)was calculated and reported using a GEE model for binomial outcomes to account for multiple recordings per patient.
6 weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Studieleder: Tamara Shipman, Abbott Medical Devices

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. september 2008

Primær færdiggørelse (Faktiske)

1. februar 2011

Studieafslutning (Faktiske)

1. juni 2014

Datoer for studieregistrering

Først indsendt

2. september 2008

Først indsendt, der opfyldte QC-kriterier

3. september 2008

Først opslået (Skøn)

4. september 2008

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

30. januar 2019

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

28. januar 2019

Sidst verificeret

1. januar 2019

Mere information

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner